{"id":192082,"date":"2026-11-13T18:42:35","date_gmt":"2026-11-13T23:42:35","guid":{"rendered":"https:\/\/wfh.org\/article\/dia-2-del-19o-taller-sobre-nttg-el-evento-concluye-con-sesiones-que-invitan-a-la-reflexion\/"},"modified":"2026-11-17T10:33:12","modified_gmt":"2026-11-17T15:33:12","slug":"dia-2-del-19o-taller-sobre-nttg-el-evento-concluye-con-sesiones-que-invitan-a-la-reflexion","status":"publish","type":"post","link":"https:\/\/wfh.org\/es\/article\/dia-2-del-19o-taller-sobre-nttg-el-evento-concluye-con-sesiones-que-invitan-a-la-reflexion\/","title":{"rendered":"D\u00eda 2 del 19\u00ba Taller sobre NTTG: El evento concluye con sesiones que invitan a la reflexi\u00f3n"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"192082\" class=\"elementor elementor-192082 elementor-191953\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-34a074c elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"34a074c\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-ffe00ed\" data-id=\"ffe00ed\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-635d99f elementor-widget elementor-widget-text-editor\" data-id=\"635d99f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>El d\u00eda 2 abarc\u00f3 cuatro sesiones que cubrieron la ingenier\u00eda de los transgenes, terapias para otros trastornos de la coagulaci\u00f3n poco comunes, perspectivas comunitarias sobre nuevas tecnolog\u00edas, y estrategias para hacerlas llegar al resto del mundo.<\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-ab98e15 elementor-widget elementor-widget-heading\" data-id=\"ab98e15\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Sesi\u00f3n 5 \u2013 \u201cMejorar los transgenes\u201d<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-4ce7665 elementor-widget elementor-widget-text-editor\" data-id=\"4ce7665\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Los ponentes presentaron m\u00e9todos a fin de hacer m\u00e1s duradera la terapia g\u00e9nica para la hemofilia A con vectores virales adenoasociados (VAA) dirigida al h\u00edgado, inclusive constructos del factor VIII que reducen el estr\u00e9s del ret\u00edculo endoplasm\u00e1tico (RE) y mejoran la secreci\u00f3n, logrando una expresi\u00f3n sostenida con menores dosis de vector. Otros m\u00e9todos abarcan un inhibidor de la SUMOilaci\u00f3n que potenci\u00f3 la expresi\u00f3n del transgene, y una fusi\u00f3n de factor IX de Padua y alb\u00famina con vida media prolongada. Se sopes\u00f3 la seguridad a largo plazo de estas estrategias, se\u00f1alando que los modelos que vinculan las v\u00edas de estr\u00e9s del RE con el c\u00e1ncer hep\u00e1tico podr\u00edan ser mucho m\u00e1s extremos que la exposici\u00f3n cl\u00ednica a VAA.<\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-790facc elementor-widget elementor-widget-heading\" data-id=\"790facc\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Sesi\u00f3n 6 \u2013 \u201cTerapias novedosas para otros trastornos de la coagulaci\u00f3n\u201d<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-aeee5fb elementor-widget elementor-widget-text-editor\" data-id=\"aeee5fb\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Los expertos analizaron estrategias precl\u00ednicas y cl\u00ednicas m\u00e1s all\u00e1 de la hemofilia, entre ellas anticuerpos mim\u00e9ticos del factor VIII administrados mediante vectores VAA; un anticuerpo contra la prote\u00edna S para la enfermedad de Von Willebrand (EVW); y m\u00e9todos con GalNAc-ARNip dirigidos al plasmin\u00f3geno y al ZPI. Tambi\u00e9n se abordaron la aplicabilidad de estos m\u00e9todos a otros trastornos de la coagulaci\u00f3n y los par\u00e1metros normativos para la reducci\u00f3n de hemorragias.<\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-0a5f3bc elementor-widget elementor-widget-heading\" data-id=\"0a5f3bc\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Sesi\u00f3n 7 \u2013 \u201cPerspectivas individuales sobre nuevas tecnolog\u00edas y terapias g\u00e9nicas\u201d<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-0bbfcdb elementor-widget elementor-widget-text-editor\" data-id=\"0bbfcdb\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Los panelistas coincidieron en que la idea de una \u201cmente sin hemofilia\u201d est\u00e1 casi al alcance de muchos pa\u00edses con ingresos altos, pero contin\u00faa siendo una meta lejana en otros lugares, y que esta visi\u00f3n tambi\u00e9n debe incluir a mujeres y ni\u00f1as, a pacientes con trastornos moderados y a quienes no tienen acceso a una atenci\u00f3n m\u00e1s amplia. El debate subray\u00f3 la necesidad de tomar decisiones compartidas, de mejorar la recopilaci\u00f3n de pruebas del mundo real sobre los pacientes que reciben tratamiento, y de indicadores de resultados hemorr\u00e1gicos espec\u00edficos para mujeres.<\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-8cc65b5 elementor-widget elementor-widget-heading\" data-id=\"8cc65b5\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Sesi\u00f3n 8 \u2013 \u201cLlegar al resto del mundo\u201d<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-df0e503 elementor-widget elementor-widget-text-editor\" data-id=\"df0e503\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>La sesi\u00f3n de clausura analiz\u00f3 c\u00f3mo la mayor\u00eda de la poblaci\u00f3n mundial queda reiteradamente excluida conforme surgen nuevas terapias. Los ponentes debatieron sobre modelos para establecer precios y maneras de seguir adelante. Las experiencias de China e India demostraron c\u00f3mo pueden avanzar programas de terapia g\u00e9nica de menor costo, al tiempo que los ponentes enfatizaron que la asequibilidad debe ir acompa\u00f1ada de infraestructura, mecanismos de registro y sistemas farmac\u00e9uticos en cada pa\u00eds.<\/p>\n<p>Para obtener m\u00e1s informaci\u00f3n sobre el 19\u00ba Taller sobre nuevas tecnolog\u00edas y terapia g\u00e9nica (NTTG) haga <a href=\"https:\/\/wfh.org\/es\/article\/el-19o-taller-sobre-nuevas-tecnologias-y-terapia-genica-marca-30-anos-de-innovacion-cientifica\/\" target=\"_blank\" rel=\"noopener\">clic aqu\u00ed<\/a>.<\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-670c2dc elementor-widget-divider--view-line elementor-widget elementor-widget-divider\" data-id=\"670c2dc\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"divider.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-divider\">\n\t\t\t<span class=\"elementor-divider-separator\">\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-44cfa84 elementor-widget elementor-widget-text-editor\" data-id=\"44cfa84\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div><i>El 19\u00ba Taller sobre nuevas tecnolog\u00edas y terapia g\u00e9nica recibe apoyo de:<\/i><\/div>\n<p><\/p>\n<div><\/div>\n<p><\/p>\n<ul>\n<li>\n<div><i>Aliada visionaria: Pfizer<\/i><\/div>\n<\/li>\n<li>\n<div><i>Aliadas colaboradoras: Regeneron, Roche, Sobi<\/i><\/div>\n<\/li>\n<li>\n<div><i>Aliada contribuyente: Incyte<\/i><\/div>\n<\/li>\n<li>\n<div><i>Agradecimiento adicional a: Metagenomi<\/i><\/div>\n<\/li>\n<\/ul>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-1c2b8bb elementor-widget elementor-widget-spacer\" data-id=\"1c2b8bb\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-71fb94b elementor-widget elementor-widget-image\" data-id=\"71fb94b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/wfh.org\/wp-content\/uploads\/2026\/11\/NTGT-Day-1-Session-1-QA-trimmed-1.jpg\" data-elementor-open-lightbox=\"yes\" data-elementor-lightbox-title=\"NTGT-Day-1---Session-1-QA-(trimmed)\" data-e-action-hash=\"#elementor-action%3Aaction%3Dlightbox%26settings%3DeyJpZCI6MTkxOTgwLCJ1cmwiOiJodHRwczpcL1wvd2ZoLm9yZ1wvd3AtY29udGVudFwvdXBsb2Fkc1wvMjAyNlwvMTFcL05UR1QtRGF5LTEtU2Vzc2lvbi0xLVFBLXRyaW1tZWQtMS5qcGcifQ%3D%3D\">\n\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"1200\" height=\"938\" src=\"https:\/\/wfh.org\/wp-content\/uploads\/2026\/11\/NTGT-Day-1-Session-1-QA-trimmed-1.jpg\" class=\"attachment-full size-full wp-image-191980\" alt=\"19th NTGT day 2: workshop speech\" srcset=\"https:\/\/wfh.org\/wp-content\/uploads\/2026\/11\/NTGT-Day-1-Session-1-QA-trimmed-1.jpg 1200w, https:\/\/wfh.org\/wp-content\/uploads\/2026\/11\/NTGT-Day-1-Session-1-QA-trimmed-1-138x108.jpg 138w, https:\/\/wfh.org\/wp-content\/uploads\/2026\/11\/NTGT-Day-1-Session-1-QA-trimmed-1-768x600.jpg 768w\" sizes=\"(max-width: 1200px) 100vw, 1200px\" \/>\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Durante el segundo y \u00faltimo d\u00eda del 19\u00ba Taller sobre nuevas tecnolog\u00edas y terapia g\u00e9nica (NTTG) \u2013realizado en Montreal, Canad\u00e1, del 12 al 13 de noviembre de 2026\u2013 se abordaron desde mejoras al dise\u00f1o de la terapia g\u00e9nica hasta la cuesti\u00f3n de qui\u00e9n se beneficiar\u00e1 de hecho con ella.<\/p>\n","protected":false},"author":13,"featured_media":191973,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[49,331,122],"tags":[],"search-category":[85],"class_list":["post-192082","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-education","category-featured-1","category-gene-therapy","search-category-article"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.8 (Yoast SEO v28.8) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>D\u00eda 2 del 19\u00ba Taller sobre NTTG: El evento concluye con sesiones que invitan a la reflexi\u00f3n | FMH - Federaci\u00f3n Mundial de Hemofilia<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/wfh.org\/es\/article\/dia-2-del-19o-taller-sobre-nttg-el-evento-concluye-con-sesiones-que-invitan-a-la-reflexion\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"D\u00eda 2 del 19\u00ba Taller sobre NTTG: El evento concluye con sesiones que invitan a la reflexi\u00f3n\" \/>\n<meta property=\"og:description\" content=\"Durante el segundo y \u00faltimo d\u00eda del 19\u00ba Taller sobre nuevas tecnolog\u00edas y terapia g\u00e9nica (NTTG) \u2013realizado en Montreal, Canad\u00e1, del 12 al 13 de noviembre de 2026\u2013 se abordaron desde mejoras al dise\u00f1o de la terapia g\u00e9nica hasta la cuesti\u00f3n de qui\u00e9n se beneficiar\u00e1 de hecho con ella.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/wfh.org\/es\/article\/dia-2-del-19o-taller-sobre-nttg-el-evento-concluye-con-sesiones-que-invitan-a-la-reflexion\/\" \/>\n<meta property=\"og:site_name\" content=\"FMH - Federaci\u00f3n Mundial de Hemofilia\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/wfhemophilia\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-13T23:42:35+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-11-17T15:33:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/wfh.org\/wp-content\/uploads\/2026\/11\/NTGT-Day-2-header.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"627\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Mitch Semienchuk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Mitch Semienchuk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/wfh.org\\\/es\\\/article\\\/dia-2-del-19o-taller-sobre-nttg-el-evento-concluye-con-sesiones-que-invitan-a-la-reflexion\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/wfh.org\\\/es\\\/article\\\/dia-2-del-19o-taller-sobre-nttg-el-evento-concluye-con-sesiones-que-invitan-a-la-reflexion\\\/\"},\"author\":{\"name\":\"Mitch Semienchuk\",\"@id\":\"https:\\\/\\\/wfh.org\\\/es\\\/#\\\/schema\\\/person\\\/4aea5b13c1966452a640eef39423925b\"},\"headline\":\"D\u00eda 2 del 19\u00ba Taller sobre NTTG: El evento concluye con sesiones que invitan a la reflexi\u00f3n\",\"datePublished\":\"2026-11-13T23:42:35+00:00\",\"dateModified\":\"2026-11-17T15:33:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/wfh.org\\\/es\\\/article\\\/dia-2-del-19o-taller-sobre-nttg-el-evento-concluye-con-sesiones-que-invitan-a-la-reflexion\\\/\"},\"wordCount\":542,\"publisher\":{\"@id\":\"https:\\\/\\\/wfh.org\\\/es\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/wfh.org\\\/es\\\/article\\\/dia-2-del-19o-taller-sobre-nttg-el-evento-concluye-con-sesiones-que-invitan-a-la-reflexion\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/wfh.org\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/NTGT-Day-2-header.jpg\",\"articleSection\":[\"Education\",\"Featured 1\",\"Gene therapy\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/wfh.org\\\/es\\\/article\\\/dia-2-del-19o-taller-sobre-nttg-el-evento-concluye-con-sesiones-que-invitan-a-la-reflexion\\\/\",\"url\":\"https:\\\/\\\/wfh.org\\\/es\\\/article\\\/dia-2-del-19o-taller-sobre-nttg-el-evento-concluye-con-sesiones-que-invitan-a-la-reflexion\\\/\",\"name\":\"D\u00eda 2 del 19\u00ba Taller sobre NTTG: El evento concluye con sesiones que invitan a la reflexi\u00f3n | FMH - Federaci\u00f3n Mundial de Hemofilia\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/wfh.org\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/wfh.org\\\/es\\\/article\\\/dia-2-del-19o-taller-sobre-nttg-el-evento-concluye-con-sesiones-que-invitan-a-la-reflexion\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/wfh.org\\\/es\\\/article\\\/dia-2-del-19o-taller-sobre-nttg-el-evento-concluye-con-sesiones-que-invitan-a-la-reflexion\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/wfh.org\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/NTGT-Day-2-header.jpg\",\"datePublished\":\"2026-11-13T23:42:35+00:00\",\"dateModified\":\"2026-11-17T15:33:12+00:00\",\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/wfh.org\\\/es\\\/article\\\/dia-2-del-19o-taller-sobre-nttg-el-evento-concluye-con-sesiones-que-invitan-a-la-reflexion\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/wfh.org\\\/es\\\/article\\\/dia-2-del-19o-taller-sobre-nttg-el-evento-concluye-con-sesiones-que-invitan-a-la-reflexion\\\/#primaryimage\",\"url\":\"https:\\\/\\\/wfh.org\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/NTGT-Day-2-header.jpg\",\"contentUrl\":\"https:\\\/\\\/wfh.org\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/NTGT-Day-2-header.jpg\",\"width\":1200,\"height\":627,\"caption\":\"19th NTGT day 2: workshop concludes with thought-provoking sessions\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/wfh.org\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/wfh.org\\\/es\\\/\",\"name\":\"FMH - Federaci\u00f3n Mundial de Hemofilia\",\"description\":\"World Federation of Hemophilia | Treatment for All\",\"publisher\":{\"@id\":\"https:\\\/\\\/wfh.org\\\/es\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/wfh.org\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/wfh.org\\\/es\\\/#organization\",\"name\":\"World Federation of Hemophilia\",\"url\":\"https:\\\/\\\/wfh.org\\\/es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/wfh.org\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/wfh.org\\\/wp-content\\\/uploads\\\/2021\\\/10\\\/WFH-LOGO-ENGLISH.svg\",\"contentUrl\":\"https:\\\/\\\/wfh.org\\\/wp-content\\\/uploads\\\/2021\\\/10\\\/WFH-LOGO-ENGLISH.svg\",\"width\":210,\"height\":63,\"caption\":\"World Federation of Hemophilia\"},\"image\":{\"@id\":\"https:\\\/\\\/wfh.org\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/wfhemophilia\\\/\"],\"description\":\"WFH is a global nonprofit improving care for people with hemophilia, von Willebrand disease, and other bleeding disorders through global advocacy.\",\"email\":\"wfh@wfh.org\",\"telephone\":\"+1 (514) 875-7944\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/wfh.org\\\/es\\\/#\\\/schema\\\/person\\\/4aea5b13c1966452a640eef39423925b\",\"name\":\"Mitch Semienchuk\",\"sameAs\":[\"analytics\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"D\u00eda 2 del 19\u00ba Taller sobre NTTG: El evento concluye con sesiones que invitan a la reflexi\u00f3n | FMH - Federaci\u00f3n Mundial de Hemofilia","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/wfh.org\/es\/article\/dia-2-del-19o-taller-sobre-nttg-el-evento-concluye-con-sesiones-que-invitan-a-la-reflexion\/","og_locale":"es_ES","og_type":"article","og_title":"D\u00eda 2 del 19\u00ba Taller sobre NTTG: El evento concluye con sesiones que invitan a la reflexi\u00f3n","og_description":"Durante el segundo y \u00faltimo d\u00eda del 19\u00ba Taller sobre nuevas tecnolog\u00edas y terapia g\u00e9nica (NTTG) \u2013realizado en Montreal, Canad\u00e1, del 12 al 13 de noviembre de 2026\u2013 se abordaron desde mejoras al dise\u00f1o de la terapia g\u00e9nica hasta la cuesti\u00f3n de qui\u00e9n se beneficiar\u00e1 de hecho con ella.","og_url":"https:\/\/wfh.org\/es\/article\/dia-2-del-19o-taller-sobre-nttg-el-evento-concluye-con-sesiones-que-invitan-a-la-reflexion\/","og_site_name":"FMH - Federaci\u00f3n Mundial de Hemofilia","article_publisher":"https:\/\/www.facebook.com\/wfhemophilia\/","article_published_time":"2026-11-13T23:42:35+00:00","article_modified_time":"2026-11-17T15:33:12+00:00","og_image":[{"width":1200,"height":627,"url":"https:\/\/wfh.org\/wp-content\/uploads\/2026\/11\/NTGT-Day-2-header.jpg","type":"image\/jpeg"}],"author":"Mitch Semienchuk","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Mitch Semienchuk","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/wfh.org\/es\/article\/dia-2-del-19o-taller-sobre-nttg-el-evento-concluye-con-sesiones-que-invitan-a-la-reflexion\/#article","isPartOf":{"@id":"https:\/\/wfh.org\/es\/article\/dia-2-del-19o-taller-sobre-nttg-el-evento-concluye-con-sesiones-que-invitan-a-la-reflexion\/"},"author":{"name":"Mitch Semienchuk","@id":"https:\/\/wfh.org\/es\/#\/schema\/person\/4aea5b13c1966452a640eef39423925b"},"headline":"D\u00eda 2 del 19\u00ba Taller sobre NTTG: El evento concluye con sesiones que invitan a la reflexi\u00f3n","datePublished":"2026-11-13T23:42:35+00:00","dateModified":"2026-11-17T15:33:12+00:00","mainEntityOfPage":{"@id":"https:\/\/wfh.org\/es\/article\/dia-2-del-19o-taller-sobre-nttg-el-evento-concluye-con-sesiones-que-invitan-a-la-reflexion\/"},"wordCount":542,"publisher":{"@id":"https:\/\/wfh.org\/es\/#organization"},"image":{"@id":"https:\/\/wfh.org\/es\/article\/dia-2-del-19o-taller-sobre-nttg-el-evento-concluye-con-sesiones-que-invitan-a-la-reflexion\/#primaryimage"},"thumbnailUrl":"https:\/\/wfh.org\/wp-content\/uploads\/2026\/11\/NTGT-Day-2-header.jpg","articleSection":["Education","Featured 1","Gene therapy"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/wfh.org\/es\/article\/dia-2-del-19o-taller-sobre-nttg-el-evento-concluye-con-sesiones-que-invitan-a-la-reflexion\/","url":"https:\/\/wfh.org\/es\/article\/dia-2-del-19o-taller-sobre-nttg-el-evento-concluye-con-sesiones-que-invitan-a-la-reflexion\/","name":"D\u00eda 2 del 19\u00ba Taller sobre NTTG: El evento concluye con sesiones que invitan a la reflexi\u00f3n | FMH - Federaci\u00f3n Mundial de Hemofilia","isPartOf":{"@id":"https:\/\/wfh.org\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/wfh.org\/es\/article\/dia-2-del-19o-taller-sobre-nttg-el-evento-concluye-con-sesiones-que-invitan-a-la-reflexion\/#primaryimage"},"image":{"@id":"https:\/\/wfh.org\/es\/article\/dia-2-del-19o-taller-sobre-nttg-el-evento-concluye-con-sesiones-que-invitan-a-la-reflexion\/#primaryimage"},"thumbnailUrl":"https:\/\/wfh.org\/wp-content\/uploads\/2026\/11\/NTGT-Day-2-header.jpg","datePublished":"2026-11-13T23:42:35+00:00","dateModified":"2026-11-17T15:33:12+00:00","inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/wfh.org\/es\/article\/dia-2-del-19o-taller-sobre-nttg-el-evento-concluye-con-sesiones-que-invitan-a-la-reflexion\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/wfh.org\/es\/article\/dia-2-del-19o-taller-sobre-nttg-el-evento-concluye-con-sesiones-que-invitan-a-la-reflexion\/#primaryimage","url":"https:\/\/wfh.org\/wp-content\/uploads\/2026\/11\/NTGT-Day-2-header.jpg","contentUrl":"https:\/\/wfh.org\/wp-content\/uploads\/2026\/11\/NTGT-Day-2-header.jpg","width":1200,"height":627,"caption":"19th NTGT day 2: workshop concludes with thought-provoking sessions"},{"@type":"WebSite","@id":"https:\/\/wfh.org\/es\/#website","url":"https:\/\/wfh.org\/es\/","name":"FMH - Federaci\u00f3n Mundial de Hemofilia","description":"World Federation of Hemophilia | Treatment for All","publisher":{"@id":"https:\/\/wfh.org\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/wfh.org\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/wfh.org\/es\/#organization","name":"World Federation of Hemophilia","url":"https:\/\/wfh.org\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/wfh.org\/es\/#\/schema\/logo\/image\/","url":"https:\/\/wfh.org\/wp-content\/uploads\/2021\/10\/WFH-LOGO-ENGLISH.svg","contentUrl":"https:\/\/wfh.org\/wp-content\/uploads\/2021\/10\/WFH-LOGO-ENGLISH.svg","width":210,"height":63,"caption":"World Federation of Hemophilia"},"image":{"@id":"https:\/\/wfh.org\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/wfhemophilia\/"],"description":"WFH is a global nonprofit improving care for people with hemophilia, von Willebrand disease, and other bleeding disorders through global advocacy.","email":"wfh@wfh.org","telephone":"+1 (514) 875-7944"},{"@type":"Person","@id":"https:\/\/wfh.org\/es\/#\/schema\/person\/4aea5b13c1966452a640eef39423925b","name":"Mitch Semienchuk","sameAs":["analytics"]}]}},"toolset-meta":{"speaker-fields":[],"article-fields":{"article-image-credit":{"type":"textfield","raw":""},"radio-5ba1c0a8":{"type":"radio","raw":"none"},"banner-link":{"type":"url","raw":""}}},"_links":{"self":[{"href":"https:\/\/wfh.org\/es\/wp-json\/wp\/v2\/posts\/192082","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wfh.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wfh.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/wfh.org\/es\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/wfh.org\/es\/wp-json\/wp\/v2\/comments?post=192082"}],"version-history":[{"count":2,"href":"https:\/\/wfh.org\/es\/wp-json\/wp\/v2\/posts\/192082\/revisions"}],"predecessor-version":[{"id":192169,"href":"https:\/\/wfh.org\/es\/wp-json\/wp\/v2\/posts\/192082\/revisions\/192169"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wfh.org\/es\/wp-json\/wp\/v2\/media\/191973"}],"wp:attachment":[{"href":"https:\/\/wfh.org\/es\/wp-json\/wp\/v2\/media?parent=192082"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wfh.org\/es\/wp-json\/wp\/v2\/categories?post=192082"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wfh.org\/es\/wp-json\/wp\/v2\/tags?post=192082"},{"taxonomy":"search-category","embeddable":true,"href":"https:\/\/wfh.org\/es\/wp-json\/wp\/v2\/search-category?post=192082"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}